Showing results (1-10 of 121) with videos related to
Sort By:
Pageof 13
Journal of the National Cancer Institute|February 17, 1993
The current status of camptothecin analogues as antitumor agentsW J Slichenmyer, E K Rowinsky, R C Donehower, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Camptothecin analogues: studies from the Johns Hopkins Oncology CenterW J Slichenmyer, E K Rowinsky, L B Grochow, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropeniaW J Slichenmyer, R C Donehower, T L Chen, et al.Seminars in Oncology|November 14, 2001
Anticancer therapy targeting the erbB family of receptor tyrosine kinasesW J Slichenmyer, D W FrySeminars in Oncology|June 1, 1992
An overview of the clinical experience with hydroxyureaR C DonehowerStem Cells (Dayton, Ohio)|January 1, 1996
The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer InstituteR C DonehowerRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Metabolic conversion of methotrexate in manR C DonehowerOncology (Williston Park, N.Y.)|February 24, 2001
Role of oral chemotherapy in colorectal cancerR C DonehowerAnti-Cancer Drugs|December 1, 1991
Taxol: a new and effective anti-cancer drugW J Slichenmyer, D D Von HoffJournal of Clinical Pharmacology|September 1, 1990
New natural products in cancer chemotherapyW J Slichenmyer, D D Von HoffPageof 13